About ADRO

Aduro Biotech, Inc. is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. Aduros lead platform is based on proprietary strains of live-attenuated, double-deleted (LADD) Listeria monocytogenes that induce a potent innate immune response and have been engineered to express tumor-associated antigens to induce tumor-specific T cell-mediated immunity. Aduro has received Breakthrough Therapy designation from the FDA for its lead LADD regimen, CRS-207 in combination with GVAX Pancreas in pancreatic cancer. The company is evaluating the proprietary immuno-oncology combination in the ongoing Phase 2b ECLIPSE clinical trial and has additional ongoing clinical trials with its LADD platform in mesothelioma and glioblastoma. The company is also developing clinical candidates using cyclic dinucleotide (CDN) synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADRO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 199.3 M 1.99301E+08 230 230 0.01% 6.48969E-05 27 K 26675
UBIO Proshares UltraPro Nasdaq Biotechnology 25.6 M 2.5617E+07 225 225 0.0% 4.30083E-05 3 K 3478
URTY ProShares UltraPro Russell2000 81.1 M 8.1125E+07 2,012 2012 0.0% 1.21132E-05 3 K 3050
UWM ProShares Ultra Russell2000 149.7 M 1.49742E+08 2,011 2011 0.0% 1.75482E-05 6 K 5648
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 1.9 B 1.9399E+09 1,461 1461 0.0% 4E-05 81 K 81174
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.39355E+09 2,245 2245 0.0% 5E-06 7 K 6940
VHT Vanguard Health Care ETF 9.1 B 9.1E+09 386 386 0.0% 2E-05 142 K 142327
VTHR Vanguard Russell 3000 ETF 479.5 M 4.795E+08 3,004 3004 0.0% 0 1 K 1341
VTI Vanguard Total Stock Market ETF 119.5 B 1.195E+11 3,575 3575 0.0% 0 199 K 198597
VTWG Vanguard Russell 2000 Growth ETF 307.1 M 3.071E+08 1,329 1329 0.01% 8E-05 23 K 23244
VTWO Vanguard Russell 2000 ETF 1.5 B 1.5E+09 2,029 2029 0.0% 4E-05 67 K 66597
VTWV Vanguard Russell 2000 Value ETF 258.2 M 2.582E+08 1,619 1619 0.0% 1E-05 2 K 2271
VXF Vanguard Extended Market ETF 7.3 B 7.3E+09 3,266 3266 0.0% 1E-05 101 K 100687
SCHA Schwab U.S. Small-Cap ETF 8.1 B 8.14785E+09 1,745 1745 0.0% 0 202 K 201814
SCHB Schwab U.S. Broad Market ETF 15.3 B 1.52769E+10 2,459 2459 0.0% 0 39 K 38927
IBB iShares Nasdaq Biotechnology Index Fund 7.0 B 6.98667E+09 219 219 0.01% 0.0001 1.0 M 1045610
ITOT iShares Core S&P Total U.S. Stock Market ETF 22.0 B 2.20343E+10 3,546 3546 0.0% 0 26 K 26148
IWC iShares Microcap ETF 800.2 M 8.00224E+08 1,388 1388 0.03% 0.0003 230 K 230097
IWM iShares Russell 2000 ETF 41.0 B 4.10203E+10 2,000 2000 0.0% 0 1.8 M 1786080
IWN iShares Russell 2000 Value ETF 8.6 B 8.5693E+09 1,391 1391 0.0% 0 83 K 83338
IWO iShares Russell 2000 Growth ETF 9.0 B 9.04593E+09 1,146 1146 0.01% 0.0001 751 K 751256
IWV iShares Russell 3000 ETF 9.3 B 9.33325E+09 2,893 2893 0.0% 0 31 K 31124
FHLC Fidelity MSCI Health Care Index ETF 369 369 0.0% 1.72365E-05 26 K 25962
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.0% 2.70828E-05 58 K 57569